These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6106487)

  • 21. [Serotonergic neurons and behavior].
    Soubrié P
    J Pharmacol; 1986; 17(2):107-12. PubMed ID: 2875217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation of GABA in the mechanism of action of psychotropic agents.
    Zakusov VV; Ostrovskaya RU; Bulayev VM
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):7-12. PubMed ID: 6126996
    [No Abstract]   [Full Text] [Related]  

  • 23. Behavioral effects of vigabatrin correlated with whole brain gamma-aminobutyric acid metabolism in audiogenic sensitive rats.
    Engelborghs S; Pickut BA; D'Hooge R; Wiechert P; Haegele K; De Deyn PP
    Arzneimittelforschung; 1998 Jul; 48(7):713-6. PubMed ID: 9706369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anxiolytic and anxiogenic beta-carbolines: tools for the study of anxiety mechanisms.
    Stephens DN; Kehr W; Duka T
    Adv Biochem Psychopharmacol; 1986; 41():91-106. PubMed ID: 2874697
    [No Abstract]   [Full Text] [Related]  

  • 25. [The neurochemistry of anxiety (a review)].
    Orlikov AB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(11):116-20. PubMed ID: 1686952
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of socio-environmental isolation on brain biochemistry, behaviour and psychoactive drug activity.
    Valzelli L
    Ann Ist Super Sanita; 1978; 14(1):173-82. PubMed ID: 40500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Behavioral effects of penicillin in experimental anxiety in rats].
    Kaluev AV; Samonina GE; Ashmarin IP
    Biull Eksp Biol Med; 1995 Oct; 120(10):352-4. PubMed ID: 8595217
    [No Abstract]   [Full Text] [Related]  

  • 28. From animal experiments to clinical trials: aspects of the transposition in psychopharmacology.
    De Montigny C
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):585-93. PubMed ID: 6131492
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of the GABA-ergic link in the development of the tranquilizing effect in cats].
    Kozlovskaia MM; Kharlamov AN; Raevskiĭ KS; Val'dman AV
    Biull Eksp Biol Med; 1981; 91(1):45-8. PubMed ID: 6111364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some behavioral effects of chlorodesmethyldiazepam and lorazepam.
    Kostowski W; Płaźnik A; Puciłowski O; Trzaskowska E; Lipińska T
    Pol J Pharmacol Pharm; 1981; 33(6):597-602. PubMed ID: 6127668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential efficacy and toxicity of GM1 ganglioside against trimethyltin-induced brain lesions in rats: comparison with protracted food restriction.
    Bollweg G; Balaban C; Cox HJ; Berra B; Sparber SB
    Neurotoxicology; 1995; 16(2):239-55. PubMed ID: 7566684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of chlordiazepoxide, buspirone and cocaine on behavior suppressed by timeout presentation.
    van Haaren F; Anderson KG
    Behav Pharmacol; 1997 Jun; 8(2-3):174-82. PubMed ID: 9833012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzodiazepines and the developing rat: a critical review.
    Tucker JC
    Neurosci Biobehav Rev; 1985; 9(1):101-11. PubMed ID: 2858075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
    Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further assessment of benzodiazepine-tricyclic antidepressant interaction. Effectiveness of combined treatment with ketazolam-nortriptyline on conflict behaviour in rats.
    Cannizzaro G; Brucato AF; Provenzano PM
    Arzneimittelforschung; 1982; 32(9):1111-3. PubMed ID: 6128985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are serotonergic neurons involved in the control of anxiety and in the anxiolytic activity of benzodiazepines?
    Thiebot MH
    Pharmacol Biochem Behav; 1986 May; 24(5):1471-7. PubMed ID: 2873593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological properties of new cyclic derivatives of phenylsuccinimide and their influence on noradrenaline, dopamine, serotonin, 5-hydroxyindoleacetic acid, gamma-aminobutyric acid concentrations and monoaminooxidase activity in animal brains.
    Chmielewska B
    Pharmazie; 1984 Apr; 39(4):259-62. PubMed ID: 6204346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.